ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 20 Issue : 1
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction [Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(6): 374-381 | DOI: 10.14744/AnatolJCardiol.2018.63549  

Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction

Aleksander Siniarski1, Rafal Grzybczak2, Pawel Rostoff1, Jaroslaw Zalewski1, Urszula Czubek1, Jadwiga Nessler1, Grzegorz Gajos1
1Department of Coronary Disease and Heart Failure, Faculty of Medicine, Jagiellonian University Medical College, John Paul II Hospital; Krakow-Poland
2Department of Cardiac Rehabilitation, John Paul II Hospital; Krakow-Poland

Objective: High-density lipoproteins (HDLs) are a very heterogeneous group of particles. Little is known about the impact of their subfractions including lipoprotein A-I (LpA-I) and lipoprotein A-I/A-II (LpA-I/A-II) on platelet function and high on-treatment platelet reactivity (HPR), particularly in the acute phase of ST-segment elevation myocardial infarction (STEMI). The aim of the study was to evaluate the relationship between serum levels of LpA-I and LpA-I/A-II and HPR in STEMI patients.
Methods: Fifty-two consecutive STEMI patients (26.9% women, mean age 60.69.1 years) were enrolled into this study. Clinical and demographic data were collected and HDL subfractions were measured by rocket immunoelectrophoresis. Platelet reactivity was assessed using light transmission aggregometry and quantitative flow cytometry.
Results: We found a positive correlation between platelet aggregation after both ADP-5 and ADP-20 stimulation and serum level of LpA-I. Compared with subjects with satisfactory platelet response to clopidogrel, patients with HPR had 32.44% higher serum level of LpA-I (p=0.021). On the other hand, patients with HPR assessed by ADP-5 stimulation had 22.13% lower serum level of LpA-I/A-II (p=0.040). Regression analysis showed that LpA-I [odds ratio (OR) 1.03; 95% confidence interval (CI) 1-1.07; p=0.049] and current smoking (OR 0.18; 95% CI 0.04-0.81; p=0.025) were independent predictors of HPR. With receiver operating characteristic (ROC) curve analysis, we designated the cut-off point at serum level of 57.52 mg/dL for LpA-I for predicting HPR (AUC=0.71, p=0.010).
Conclusion: This study showed that higher serum level of LpA-I measured in the acute phase of STEMI is an independent risk factor for HPR. Our study is the first to demonstrate an important and distinct activity of LpA-I and LpA-I/A-II that can prove pleiotropic and different functions of HDL subfractions in acute STEMI.

Keywords: high-density lipoproteins, lipoprotein A-I, platelets, high platelet reactivity, ST-elevation, myocardial infarction


Aleksander Siniarski, Rafal Grzybczak, Pawel Rostoff, Jaroslaw Zalewski, Urszula Czubek, Jadwiga Nessler, Grzegorz Gajos. Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction. Anatol J Cardiol. 2018; 19(6): 374-381

Corresponding Author: Grzegorz Gajos, Poland


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright 2018 Turkish Society of Cardiology